Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2006Journal of Clinical Apheresis

Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune‐mediated disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJames N. GeorgeUniversity of Oklahoma Health Sciences CenterRWRobert D. WoodsonUniversity of MinnesotaJKJoseph E. KissVitalant

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

George et al. (2006) studied this question.

synapsesocial.com/papers/6a9d4cd834685bd77029f8a9https://doi.org/10.1002/jca.20091
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions1997 · 2,201 citations
  2. 2Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy2004 · 283 citations
  3. 3Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature2004 · 120 citations
  4. 4Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura2003 · 90 citations